Medical Policies
Home
Search Bar
Category Filter
Policies & Guidelines
Advanced Imaging
Draft Policies
Autism Spectrum Mandate
Behavioral Health
Chronic Condition Management
Genetic Testing
Draft Genetic Testing Policies
Hemophilia Drugs
Draft Hemophilia Drug Policies
Final Hemophilia Drug Policies
Hemophilia Drug Prior Authorization
Medical Policies
Draft Medical Policies
Final Medical Policies
Pre-Service Review (Precertification/Predetermination)
Provider-Administered Drug Policies
Draft Provider-Administered Drug Policies
Drug Wastage Program
Final Provider-Administered Drug Precertification Policies
Mandatory Site of Service
Provider-Administered Drug Claim Edit Policies
Voluntary Site of Service
Radiation Therapy
Draft Policies
Self-Administered Drug Policies
Draft Self-Administered Drug Policies
Final Self-Administered Drug Policies
Self-Administered Drug Prior Authorization Forms
Transgender Services
Asset Publisher
< Back to Final Medical Policies page
Final Policies - Laboratory
Policy #
Policy Title
Print View
MP-062
High Sensitivity C-Reactive Protein
MP-063
Fetal Fibronectin Enzyme Immunoassay
MP-071
Allergy Testing
MP-096
Antiprothrombin Antibody
MP-142
B-Natriuretic Peptide
MP-155
Measurement of Lipoprotein-Associated Phospholipase A2 in the Assessment of Cardiovascular Risk
MP-161
Serologic Diagnosis of Celiac Disease
MP-165
Antigen Leukocyte Antibody Test
MP-195
Serum Tumor Markers for Breast and Gastrointestinal Malignancies
MP-196
End-Tidal Carbon Monoxide Measurement (ETCOc)
MP-200
Evaluation of Biomarkers for Alzheimer Disease
MP-239
Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor
MP-264
HIV Genotyping and Phenotyping
MP-285
Serum Antibodies for the Diagnosis of Inflammatory Bowel Disease
MP-322
Laboratory Testing for HIV Tropism
MP-341
Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease
MP-353
Anti-CCP Testing for Rheumatoid Arthritis
MP-378
Intracellular Micronutrient Analysis
MP-393
Bone Turnover Markers for the Diagnosis and Management of Osteoporosis and Diseases Associated With High Bone Turnover
MP-407
Fecal Analysis in the Diagnosis of Intestinal Dysbiosis
MP-426
Multi-marker Serum-Testing Related to Ovarian Cancer
MP-428
Systems Pathology in Prostate Cancer
MP-445
Serum Biomarker Human Epididymis Protein 4 (HE4)
MP-448
Serum Holotranscobalamin as a Marker of Vitamin B12 (Cobalamin) Status
MP-472
Fecal Calprotectin Testing
MP-510
Measurement of Serum Antibodies to Selected Biologic Agents
MP-545
Human Leukocyte Antigen (HLA) Testing for Celiac Disease
MP-548
Identification of Microorganisms Using Nucleic Acid Probes
MP-562
Multianalyte Assays With Algorithmic Analyses for Predicting Risk of Type 2 Diabetes
MP-563
Serum Biomarker Tests for Multiple Sclerosis
MP-564
Biomarker and Disease Activity Testing for Rheumatoid Arthritis
MP-565
Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases
MP-566
Drug Testing
MP-567
Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease
MP-570
Proteomic Testing for Systemic Therapy in Non-Small Cell Lung Cancer
MP-584
Fecal Microbiota Transplantation
MP-592
Laboratory Tests for Chronic Heart Failure and Heart Transplant Rejection
MP-613
Nutrient/Nutritional Panel Testing
MP-707
Protein Biomarkers for Diagnosis and Risk Assessment of Prostate Cancer
MP-711
Plasma-Based Proteomic Screening of Pulmonary Nodules
MP-732
Testing Serum Vitamin D Levels
MP-746
Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes
MP-758
Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis
Hidden